SREBF2 and ovarian carcinoma: Cai et al. demonstrated that inhibition of Serine Protease 8 (PRSS8)/SCNN1A by sterol regulatory element binding protein 2 (SREBF2) reduced the cell proliferation, migration, and epithelial–mesenchymal transformation of ovarian cancer [53].